Results 71 to 80 of about 5,875,026 (205)
Letterer–Siwe Disease (LSD): A Case Report
Sudan Journal of Medical Sciences, 2018 Background: Letterer–Siwe Disease (LSD) is one of the variants of Langerhans cell histiocytosis (LCH), which is considered as a rare disease that affects many systems in the body; it is characterized by monoclonal migration and proliferation of specific ...
Suad H. H. +3 more
doaj +1 more source
Immunotherapy of Histiocytosis-X
Hematology/Oncology Clinics of North America, 1987 This article focuses on the interaction of histiocytosis-X and the immunotherapeutic agent, suppression. Studies with this and other agents have presented us with invaluable insights into the nature of histiocytosis-X.
openaire +2 more sources
2-Chlorodeoxyadenosine to Treat Refractory Histiocytosis X
, 1993 To the Editor: Treatment of histiocytosis X is palliative at best. It includes corticosteroids, alkylating agents, antimetabolites, vinca alkaloids, and irradiation 1 .
Saven, Alan +7 more
core +1 more source
LCH-Histiocytosis from Langerhans Cells in Craniofacial Region
Česká Stomatologie a Praktické Zubní Lékařství, 2005 The authors retrospectively analyze the occurrence of histiocytosis from Langerhans cells (LCH) in a group of patients from the Children Stomatological Clinic in Prague - Motol from the years 1998-2003.
M. Hubáček, J. Kozák
doaj
Epidural spinal cord compression in Langerhans cell histiocytosis: A case report
, 2013 Langerhans cell histiocytosis, also known as histiocytosis X, is a rare proliferative disorder of histiocytes. Spinal involvement in the course of Langerhans cell histiocytosis in adult is rare, and epidural location is exceptional.
MONTEMURRO, NICOLA +2 more
core +1 more source
Langerhans cell histiocytosis in children: a case report and brief review of the literature
PAMJ Clinical Medicine, 2019 Langerhans cell histiocytosis (LCH), formerly known as histiocytosis X, is a non-malignant disease involving clonal proliferation of Langerhans cells. It is an orphan disease affecting mainly the child and the young adult.
Zakaria El Ouali +7 more
doaj +1 more source
Rare Tumors, 2017 Langerhans cell sarcoma of the skin is a rare tumor with aggressive behavior. There are reports of Langerhans cell sarcoma involving the skin in patients with underlying systemic Langerhans cell histiocytosis.
Alejandro Peralta Soler +2 more
doaj +1 more source
Monoclonal antibody against histiocytosis X cells [PDF]
, 1992 Monoclonal antibody against histiocytosis X cells (HXCs) was established. The antigen was the cell membrane of HXCs from the submandibular lesion of a 63-year-old man who had been dignosed as an adult type of histiocytosis X (HX) and whose HXCs had ...
Ishikawa, Makoto +2 more
core
Juvenile xanthogranuloma: non-X histiocytosis with systemic involvement.
, 1992 Two patients with different patterns of soft tissue and bone involvement demonstrate the variability of extracutaneous manifestations of juvenile xanthogranuloma, a non-X histiocytosis, better known to dermatologists than to ...
Caro, P +3 more
core +1 more source
Langerhans cell histiocytosis presented as bilateral otitis media and mastoiditis
The Turkish Journal of Pediatrics, 2008 Langerhans cell histiocytosis (LCH) is a rare disease that may affect multiple organs. The etiology of LCH remains unclear to date. It is currently believed that clonal accumulation and proliferation of CD1a-positive Langerhans cells are causative.
Charalampos E Skoulakis +5 more
doaj